Daniel W. Drolet
Gilead Sciences (United States), Wildlife Information Liaison Development
Papers
1
Total Citations
56
H-Index
1
About
Daniel W. Drolet is a pioneering researcher in the field of nucleic acid chemistry and combinatorial biology, best known for his contributions to aptamer technology and the SELEX (Systematic Evolution of Ligands by Exponential Enrichment) process. His most notable work, published in 1999 and cited 56 times, focused on dramatically increasing the efficiency of aptamer discovery by adapting the SELEX platform for high-throughput automation. This advancement was significant for the broader scientific community, as aptamers — synthetic nucleic acid molecules capable of binding target molecules with remarkable specificity and affinity — have wide-ranging applications in diagnostics, therapeutics, and biosensor development. By engineering a more streamlined, automated version of the SELEX methodology, Drolet helped lower the technical barriers to aptamer selection, enabling researchers across disciplines to more rapidly identify high-affinity ligands for diverse molecular targets. His work sits at the intersection of combinatorial chemistry and molecular biology, and his contributions have helped lay the groundwork for modern aptamer-based technologies that continue to influence drug development and precision medicine research today.
Research Focus
Key Achievements
Top Papers
- 1